The Dow Jones industrials and S&P 500 reversed higher. The small-cap S&P 600 hasn't hit bear-market territory, but chances that small and midcap stocks will enter a 10% decline are rising.
GRENOBLE, France, April 24, 2024--Kalray (Euronext Growth Paris: ALKAL), a leading provider of hardware and software solutions to accelerate data intensive workflows from Cloud to Edge, announced that it has extended its collaboration with Arm by joining Arm Total Design. Through a deeper connection to industry leaders who are leveraging Arm® Neoverse™ Compute Subsystems (CSS), Kalray can help more companies integrate its unique AI and data acceleration technology and help Arm ecosystem partners
Q1 2024 Ameriprise Financial Inc Earnings Call
Scott Paczensky was travelling at nearly 70mph as he did not realise the speed limit had changed on the A20
Paul Bates says there’s no part of an animal that cannot be eaten
Read what the stars mean for you today, from Taurus to Gemini
Luka Doncic scored 32 points and the Dallas Mavericks overcame the return of Clippers superstar Kawhi Leonard to beat Los Angeles 96-93 on Tuesday night and tie their Western Conference first-round playoff series at a game apiece. Leonard had 15 points and seven rebounds in 35 minutes of his first game since March 31. Kyrie Irving added 23 points for the Mavs, who led most of the game two days after they trailed by 29 points and eventually lost 109-97.
Expert advice for getting your garden into gear — plus the Londoners who have discovered their green thumbs
Brazil Iron calls itself a sustainable mining company. Local residents call its project a disaster.
ZUG, Switzerland, April 24, 2024--Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2024.
WithSecure Corporation, Interim report release 1 January – 31 March 2024, 24 April 2024 at 8.00 EEST WithSecure Interim report 1 January – 31 March 2024: Elements Company profitability developing positively, despite slow start of the year Highlights of January – March 2024 (“first quarter”) Annual Recurring Revenue (ARR) (1) for Elements Cloud (2) increased by 10% to EUR 80.5 million (EUR 73.4 million)Elements Cloud ARR increase from previous quarter was 3%Net Revenue Retention for Elements Clou
Hydro’s adjusted EBITDA for the first quarter of 2024 was NOK 5,411 million, down from NOK 7,525 million for the same quarter last year. Lower aluminium sales prices, Extrusions volumes and recycling margins, and higher fixed costs negatively impacted results, partly offset by lower raw material costs. This resulted in an adjusted RoaCE of 5.6 percent over the last twelve months. Results down on weaker demand and recycling margins, revenue drivers increasingIncreasing recycling and post-consumer
Recognition given for achievement in commercializing Joenja® (leniolisib), a first-in-class medication brought to market 10 years after disease state, APDS, was first characterized Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is pleased to announce its recognition as an Industry Innovator by the National Organization for Rare Disorders (NORD®) at the Rare Impact Awards on June 8, 2024. The Rare Impact Awards h
OSLO, Norway, April 24, 2024--Elliptic Labs is shipping its 100% software-only AI Virtual Human Presence Sensor on four models of Lenovo’s ThinkPad P Series workstation laptops .
Photo_IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma Photographed from left to right:•Cristina Marti, Director API Sales and Strategy, IMCD Group•Gianluca Galimberti, General Manager, Cobapharma•Tess Hendriks, Legal Counsel M&A, IMCD Group•Fenna van Zanten, Director M&A, IMCD Group•Jose Alcover, Managing Director, IMCD Iberia & Maghreb ROTTERDAM, The Netherlands 24 April 2024 – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and
La Hulpe, Belgium – 24 April 2024, 7:00 a.m. CET – Unifiedpost Group SA (Euronext Brussels: UPG) (“Unifiedpost”), a leader in cloud-based business process solutions, will present an overview of its mid-term strategy on Tuesday, 30 April 2024.The event will take place from 2:00pm to 4:00pm CET on Tuesday, 30 April 2024. The presenting team will be Hans Leybaert, CEO, Koen De Brabander, CFO, and some of the group’s business leaders. The agenda for the day is as follows: Introductions Key objective
The Netherlands, 24 April 2024 Vopak reports strong Q1 2024 results and increases FY 2024 outlook Key highlights Q1 2024 Improve Increased net profit -including exceptional items1- in Q1 2024 to EUR 106 million, an improvement of 3% year-on-year, driven by favorable storage demand across different geographies and marketsIncreased proportional EBITDA -excluding exceptional items1- in Q1 2024 to EUR 298 million, an improvement of 9% year-on-year when adjusted for divestment impacts of EUR 21 milli
Good start to the year _PRESS RELEASE_ First quarter 2024 standard sales of €1,692 million, up +2.8% organically year-on-year and up +4.7% excluding Other activitiesElectrification businesses up +6.7% organically, reflecting double digit growth in Generation & Transmission segment and an acceleration in electrification trends globally Record adjusted backlog for Generation & Transmission, mainly subsea-driven, at €6.7 billion, up +10.2% compared to December 2023Electrification Pure Player profil
The Global Chewing Gum Market Size was Valued at USD 13.83 Billion in 2023 and the Worldwide Chewing Gum Market Size is Expected to Reach USD 19.64 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Meiji Co., Ltd., Mondelez International, Inc., Wrigley Company (Mars, Incorporated), The Hershey Company, Perfetti Van Melle Group B.V., Lotte Corporation, Ferrero International S.A., Nestlé S.A., Cadbury Adams (Kraft Heinz Company), Gumli
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. Q1 2024 Q1 2023 % change €m €m ActualCER1Growth platforms2509.7452.012.8%16.2%New medicines345.514.3n/an/aSomatuline®257.8263.2-2.0%-1.3%Other9.512.4-23.8%-20.5%Total Sales822.4741.910.9%13.3% Highlights Total-sales growth of 13.3% at CER1, or 10.9% as reported, driven by the 16.2%1 increase in sales of the growth platforms2
Group sales grew by 2%1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there will be no further material impact of COVID-19 sales declineDue to the appratioss fn of the Swiranc against most currencies, sales were 6% lower when reported in CHFPharmaceuticals Division base business2 grew by 7%, driven by strong sales of medicines to treat severe diseases, such
Yahoo Finance